
1001 - 5000 employés
Fondée en 2002
🧬 Biotechnologie
💊 Pharmaceutique
🏥 Santé
💰 €661 250 000 Post-IPO Debt en 2025-09
Biotechnology • Pharmaceuticals • Healthcare
Alnylam Pharmaceuticals est une entreprise biopharmaceutique pionnière dans le développement de traitements fondés sur l’interférence ARN (RNAi), qui permettent de réduire au silence les gènes responsables de maladies. L’entreprise développe des médicaments basés sur l’RNAi pour traiter des maladies rares et fréquentes. Elle dispose d’un pipeline, de produits approuvés et de capacités de production axés sur la mise au point de traitements transformateurs, notamment contre l’amylose, la porphyrie hépatique aiguë et l’hyperoxalurie primaire. Alnylam accorde une grande importance à l’innovation scientifique, au développement centré sur les patients et à la responsabilité d’entreprise.
🕒 il y a 1 jour
🌽 Illinois, Missouri – Distant
💵 $204 000 - $276 000 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
👻 Score fantôme 0%
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de Alnylam Pharmaceuticals, pas via un site d'emploi
Repérée par Remote Rocketship il y a 1 jour
Toujours ouverte sur le site de Alnylam Pharmaceuticals. Vérifiée il y a 20 minutes.

1001 - 5000 employés
Fondée en 2002
🧬 Biotechnologie
💊 Pharmaceutique
🏥 Santé
💰 €661 250 000 Post-IPO Debt en 2025-09
Biotechnology • Pharmaceuticals • Healthcare
Alnylam Pharmaceuticals est une entreprise biopharmaceutique pionnière dans le développement de traitements fondés sur l’interférence ARN (RNAi), qui permettent de réduire au silence les gènes responsables de maladies. L’entreprise développe des médicaments basés sur l’RNAi pour traiter des maladies rares et fréquentes. Elle dispose d’un pipeline, de produits approuvés et de capacités de production axés sur la mise au point de traitements transformateurs, notamment contre l’amylose, la porphyrie hépatique aiguë et l’hyperoxalurie primaire. Alnylam accorde une grande importance à l’innovation scientifique, au développement centré sur les patients et à la responsabilité d’entreprise.
• Lead strategic engagement and contracting with target key accounts to drive growth, revenue, joint value creation, and access to Alnylam products • Develop and execute comprehensive account strategies for target accounts • Analyze information from multiple sources to identify and prioritize business opportunities • Co-develop strategies, program objectives, and KPIs with the Alnylam Leadership Team • Prioritize solutions, programs, and pull-through tactics for sustainable growth and mutual value creation • Anticipate market and customer developments and adjust account strategy • Partner with healthcare systems and organized customers to foster innovation in care through adoption of Alnylam products • Engage senior stakeholders to influence policies, decisions, and perceptions • Facilitate introductions of new products and indications and support strategic account budget allocation • Maximize access to Alnylam products and identify programs that enhance care systems and clinical decision-making • Provide scientific, clinical, and technological insights, education, and information • Build and maintain relationships with senior stakeholders in target accounts • Establish treatment pathways and protocols to support patient identification and care delivery • Direct other field teams in identifying and prioritizing stakeholders • Negotiate, review, and agree contracts with strategic account stakeholders • Collaborate with functional and business leaders to incorporate customer insights into strategic planning • Support contracting and initiatives with national organized customers • Measure, report, and communicate value delivered • Share insights from customer engagement
• Bachelor’s degree, with emphasis in Accounting, Marketing, Business Administration or equivalent work experience in business management • Minimum 7 years of experience in B2B selling in a life sciences environment • Previous account management experience with health systems and/or hospitals/IDNs • Ability to understand and communicate complex scientific concepts to a range of stakeholders • Executive presence and communication skills to engage with a C-Suite audience • Expertise in dynamic market access value models, including value-based propositions, budget impact, and cost-effectiveness models • Strong written and oral communication skills • Ability to synthesize data and translate it into clear commercial strategies and plans • Ability to mobilize cross-functional teams and lead without direct authority in a highly matrixed environment • Understanding of the IDN environment, including coverage and reimbursement, pricing and contracting, formulary management, and health technology assessment • Strong analytical and critical-thinking skills • Ability to synthesize qualitative and quantitative multi-source information • Knowledge of value-based healthcare and outcome-based models • Ability to interact and negotiate with C-suite customers • Highly proficient in Microsoft Excel, Word, and PowerPoint • Master’s degree/MBA preferred • Active membership of relevant pharmaceutical associations beneficial
• Annual short-term incentive award (e.g., bonus or sales incentive) • Annual long-term incentive award (e.g., equity) • Medical coverage • Dental coverage • Vision coverage • Life insurance • Disability insurance • Lifestyle reimbursement program • Flexible spending accounts • Health savings accounts • 401(k) with a generous company match • Paid time off • Wellness days • Holidays • Two company-wide recharge breaks • Family resources and leave
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 1 jour
Director of Digital Analytics turning retailer and platform data into measurement and growth decisions. Helping PLTFRM’s consumer-brand clients improve sales, media, content, and assortment performance.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 1 jour
HEOR Director advancing global oncology evidence strategies for Corcept Therapeutics, a cortisol-modulation company. Leading real-world studies, economic modeling, HTA submissions, and payer engagement.
🇺🇸 États-Unis – Télétravail
💵 $192 000 - $250 000 / an
💰 €525 300 Post-IPO Equity en 2012-04
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 1 jour
Compensation Director leading pay strategy, salary structures, incentives, and compliance. Advising leaders and managing compensation programs at CRC Group, a specialty insurance distributor.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 1 jour
Atlassian Delivery Director overseeing enterprise platform delivery, client relationships, and engagement financials. Leading Atlassian practice growth and globally distributed consulting teams at AI-first Cprime.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 1 jour
Service delivery director leading IT managed services across cloud and enterprise application accounts. Managing customer governance, delivery performance, profitability, RFPs, and SOWs.
🗣️🇺🇸🇬🇧 Anglais requis